These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7650076)

  • 21. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic drugs: how to reduce the risk of tardive dyskinesia.
    DeVeaugh-Geiss J
    Geriatrics; 1979 Jul; 34(7):59-61, 66. PubMed ID: 36330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive dyskinesia and current dose of neuroleptic drugs.
    Kolakowska T; Williams AO; Ardern M
    Arch Gen Psychiatry; 1985 Sep; 42(9):925. PubMed ID: 2864034
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tardive dyskinesia in psychogeriatric patients: a five-year follow-up.
    Mehta D; Mehta S; Mathew P
    J Am Geriatr Soc; 1977 Dec; 25(12):545-7. PubMed ID: 21899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive dyskinesia in an outpatient population: prevalence and predisposing factors.
    Yassa R; Ananth J; Cordozo S; Ally J
    Can J Psychiatry; 1983 Aug; 28(5):391-4. PubMed ID: 6138143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia.
    Souza RP; Remington G; Meltzer HY; Lieberman JA; Kennedy JL; Wong AH
    Int Clin Psychopharmacol; 2010 Sep; 25(5):264-9. PubMed ID: 20436352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.
    Kane JM; Smith JM
    Arch Gen Psychiatry; 1982 Apr; 39(4):473-81. PubMed ID: 6121548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tardive dyskinesia: characterization and prevalence in a statewide system.
    Bell RC; Smith RC
    J Clin Psychiatry; 1978 Jan; 39(1):39-47. PubMed ID: 580260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1979 Jun; 63(3):195-8. PubMed ID: 39307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticholinergic antiparkinsonian drugs in psychiatry.
    Boodhoo JA; Sandler M
    Br J Hosp Med; 1991 Sep; 46(3):167-9. PubMed ID: 1681972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinguishing akathisia and tardive dyskinesia: a review of the literature.
    Munetz MR; Cornes CL
    J Clin Psychopharmacol; 1983 Dec; 3(6):343-50. PubMed ID: 6139392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV
    J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiparkinsonics, neuroleptics, and tardive dyskinesia.
    Mallya A; Jose C; Baig M; Williams R; Cho D; Mehta D; Volavka J
    Biol Psychiatry; 1979 Aug; 14(4):645-9. PubMed ID: 39640
    [No Abstract]   [Full Text] [Related]  

  • 40. Tardive dyskinesia and current dose of neuroleptic drugs.
    Kolakowska T; Williams AO; Ardern M
    Arch Gen Psychiatry; 1986 Jun; 43(6):614. PubMed ID: 2871820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.